MK-4031

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4031, covering 2011-02-09 to 2011-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303) [Phase 4]

See pricing